scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1012483791 |
P356 | DOI | 10.1038/KI.1997.80 |
P698 | PubMed publication ID | 9027740 |
P2093 | author name string | Gassmann M | |
Kvietikova I | |||
Wenger RH | |||
Marti HH | |||
P2860 | cites work | A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation | Q24294741 |
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension | Q24307473 | ||
Purification and characterization of hypoxia-inducible factor 1 | Q28678375 | ||
The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site | Q34779815 | ||
Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 alpha | Q38356865 | ||
Transcriptional regulation by CREB and its relatives | Q40847156 | ||
Increased erythropoietin secretion in human hepatoma cells by N6-cyclohexyladenosine | Q41668340 | ||
Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia | Q42166628 | ||
Hypoxic Regulation of Lactate Dehydrogenase A | Q57378005 | ||
Hypoxia and cobalt stimulate lactate dehydrogenase (LDH) activity in vascular smooth muscle cells | Q72634860 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hypoxia | Q105688 |
P304 | page(s) | 564-566 | |
P577 | publication date | 1997-02-01 | |
P1433 | published in | Kidney International | Q6404823 |
P1476 | title | The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive | |
P478 | volume | 51 |
Q74535979 | A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha |
Q46935853 | Adenosine produced via the CD73/ecto-5'-nucleotidase pathway has no impact on erythropoietin production but is associated with reduced kidney weight. |
Q33994896 | Apparent PKA activity responds to intermittent hypoxia in bone cells: a redox pathway? |
Q39462744 | Dynamic alterations in integrin α4 expression by hypoxia are involved in trophoblast invasion during early implantation |
Q40898952 | ERK activation upon hypoxia: involvement in HIF-1 activation |
Q86893314 | Erythropoietin |
Q83309375 | Erythropoietin production: Molecular mechanisms of the antagonistic actions of cyclic adenosine monophosphate and interleukin-1 |
Q54118976 | Expression of Hypoxia Inducible Factor 1alpha Is Protein Kinase A-dependent in Primary Cortical Astrocytes Exposed to Severe Hypoxia. |
Q27311433 | Functional and transcriptional induction of aquaporin-1 gene by hypoxia; analysis of promoter and role of Hif-1α |
Q38518910 | Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes |
Q38320250 | Hypoxia induces epithelial amphiregulin gene expression in a CREB-dependent manner |
Q37439991 | Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function |
Q42049779 | Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions |
Q38171333 | Oxygen regulates molecular mechanisms of cancer progression and metastasis |
Q33374284 | Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection |
Q34934915 | Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics |
Q33840307 | The Drosophila mitochondrial ribosomal protein mRpL12 is required for Cyclin D/Cdk4-driven growth |
Q38343290 | The PAI-1 gene as a direct target of endothelial PAS domain protein-1 in adenocarcinoma A549 cells |
Q35069403 | The α and Δ isoforms of CREB1 are required to maintain normal pulmonary vascular resistance |
Q33770277 | Therapeutic targets for hypoxia-elicited pathways |
Q39889775 | Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer |
Search more.